Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk?
- PMID: 16157083
- DOI: 10.1007/s11906-005-0075-3
Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk?
Abstract
C-reactive protein (CRP) and urinary albumin excretion are both determinants of cardiovascular risk. The first is closely related to systemic and vascular low-grade inflammation, the latter is considered to be a marker of endothelial dysfunction. Because of these properties, one might presume them to be closely interrelated. In this article, we review the available evidence concerning the relationships of CRP and urinary albumin excretion, with each other and with other cardiovascular risk markers and factors. Should they be considered as dependent or independent risk markers, and which risk markers might be present in the cardiovascular risk estimation formula of the near future? The reasons that this formula might or should include CRP and urinary albumin excretion, rather than diabetes mellitus and the metabolic syndrome, are discussed.
Similar articles
-
C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk.Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):593-8. doi: 10.1161/01.atv.0000013786.80104.d4. Arterioscler Thromb Vasc Biol. 2002. PMID: 11950696
-
Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women.J Intern Med. 2001 Dec;250(6):502-7. doi: 10.1046/j.1365-2796.2001.00914.x. J Intern Med. 2001. PMID: 11902818
-
Evaluation of ultrasensitive CRP and microalbuminuria as cardiovascular risk markers in type 2 diabetic moroccan patients.Tunis Med. 2017 Novembre;95(11):982-987. Tunis Med. 2017. PMID: 29877557
-
[Microalbuminuria--underestimated cardiovascular risk factor].Przegl Lek. 2005;62 Suppl 2:15-8. Przegl Lek. 2005. PMID: 16623111 Review. Polish.
-
Microalbuminaria and the risk of atherosclerosis. Clinical epidemiological and physiological investigations.Dan Med Bull. 2000 Apr;47(2):63-78. Dan Med Bull. 2000. PMID: 10822799 Review.
Cited by
-
Statin therapy in renal disease: harmful or protective?Curr Atheroscler Rep. 2007 Jan;9(1):18-24. doi: 10.1007/BF02693936. Curr Atheroscler Rep. 2007. PMID: 17169242 Review.
-
The glycocalyx--linking albuminuria with renal and cardiovascular disease.Nat Rev Nephrol. 2015 Nov;11(11):667-76. doi: 10.1038/nrneph.2015.162. Epub 2015 Oct 13. Nat Rev Nephrol. 2015. PMID: 26460356 Review.
-
Development of microalbuminuria in essential hypertension.Curr Hypertens Rep. 2006 May;8(2):171-7. doi: 10.1007/s11906-006-0015-x. Curr Hypertens Rep. 2006. PMID: 16672152 Review.
-
Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: a double blind, randomized, placebo-controlled, cross-over trial.Rev Diabet Stud. 2008 Summer;5(2):102-9. doi: 10.1900/RDS.2008.5.102. Epub 2008 Aug 10. Rev Diabet Stud. 2008. PMID: 18795212 Free PMC article.
-
Statin therapy in renal disease: harmful or protective?Curr Diab Rep. 2007 Dec;7(6):467-73. doi: 10.1007/s11892-007-0079-2. Curr Diab Rep. 2007. PMID: 18255012
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous